Hello

Your subscription is almost coming to an end. Don’t miss out on the great content on Nation.Africa

Ready to continue your informative journey with us?

Hello

Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and in-depth features.

Reclaim your full access. Click below to renew.

Subscribe for a month to get full access

Premium

US approves Gilead's remdesivir drug for Covid-19 patients

US President Donald Trump speaks about the use of first drug shown to help coronavirus patients that is made by Gilead in the Oval Office of the White House on May 1, 2020, in Washington, DC. PHOTO | JIM WATSON | AFP

By  AFP

What you need to know:

  • US medical officials have announced evidence from a trial that remdesivir helped patients with serious cases of Covid-19 recover faster.

Washington, DC

Gilead's antiviral drug remdesivir has been authorised by US regulators for emergency use on coronavirus patients, President Donald Trump announced Friday.

Also Read

In the headlines